BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8105944)

  • 41. Can low-calcium peritoneal dialysis solution safely replace the standard calcium solution in the majority of chronic peritoneal dialysis patients?
    Buijsen CG; Struijk DG; Huijgen HJ; Boeschoten EW; Wilmink JM
    Perit Dial Int; 1996; 16(5):497-504. PubMed ID: 8914179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients.
    van der Sande FM; Cheriex EC; van Kuijk WH; Leunissen KM
    Am J Kidney Dis; 1998 Jul; 32(1):125-31. PubMed ID: 9669433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Total dialysate calcium effects on calcium balance during dialysis.
    Eftimovska-Otovic N; Babalj-Banskolieva E; Bogdanoska-Kostadinoska S; Milovanceva-Popovska M; Grozdanovski R
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):25-30. PubMed ID: 24566012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of low calcium dialysate on left ventricular diastolic function in peritoneal dialysis patients.
    Wang Z; Wen Y; Liang J; Liang X; Shi W
    Ren Fail; 2016 Nov; 38(10):1665-1671. PubMed ID: 27759470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcium-free hemodialysis for the management of hypercalcemia.
    Koo WS; Jeon DS; Ahn SJ; Kim YS; Yoon YS; Bang BK
    Nephron; 1996; 72(3):424-8. PubMed ID: 8852491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intradialytic and interdialytic effects of treatment with 1.25 and 1. 75 Mmol/L of calcium dialysate on arterial compliance in patients on hemodialysis.
    Kyriazis J; Stamatiadis D; Mamouna A
    Am J Kidney Dis; 2000 Jun; 35(6):1096-103. PubMed ID: 10845823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Simple treatment of tumor-induced hypercalcemia: i.v. aminohydroxypropylidene biphosphonate].
    Portmann L; Häfliger JM; Bill G; Burckhardt P
    Schweiz Med Wochenschr; 1983 Dec; 113(51):1960-3. PubMed ID: 6318306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful treatment with assisted automated peritoneal dialysis using 4.25% glucose dialysate for an elderly patient with refractory heart failure.
    Toda N; Iwaki R; Oishi K; Takasu Y; Komiya T
    CEN Case Rep; 2021 Feb; 10(1):121-125. PubMed ID: 32930999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of dialysis in the treatment of severe hypercalcemia: report of two cases successfully treated with hemodialysis and review of the literature.
    Cardella CJ; Birkin BL; Rapoport A
    Clin Nephrol; 1979 Dec; 12(6):285-90. PubMed ID: 160852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypercalcemia in a peritoneal dialysis patient.
    Prichard S; Fried L
    Perit Dial Int; 2001; 21(4):420-7. PubMed ID: 11587413
    [No Abstract]   [Full Text] [Related]  

  • 51. The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patients.
    Demirci MS; Ozkahya M; Asci G; Sevinc E; Yilmaz M; Demirci C; Toz H; Basci A; Ok E
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S15-7. PubMed ID: 19270206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical application of low calcium peritoneal dialysate.
    Kawanishi H; Tsuchiya T; Namba S; Takahashi N; Toyota T; Fukuma K; Kawai T
    ASAIO Trans; 1991; 37(3):M404-6. PubMed ID: 1751210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Symptomatic hypercalcemia in a diabetic patient undergoing continuous ambulatory peritoneal dialysis: value of bone biopsy in the diagnosis and management.
    Frazao J; Coburn JW
    Am J Kidney Dis; 1995 Nov; 26(5):831-5. PubMed ID: 7485141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of calcitriol and maxacalcitol administered into peritoneal dialysate bags in peritoneal dialysis patients.
    Hamada C; Hayashi K; Shou I; Inaba M; Ro Y; Io H; Maeda K; Fukui M; Tomino Y
    Perit Dial Int; 2005; 25(6):570-5. PubMed ID: 16411524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate.
    Hou SH; Zhao J; Ellman CF; Hu J; Griffin Z; Spiegel DM; Bourdeau JE
    Am J Kidney Dis; 1991 Aug; 18(2):217-24. PubMed ID: 1867178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Denosumab for the treatment of bisphosphonate resistant hypercalcemia in a hemodialysis patient.
    Dahmani O; Sophoclis C; Kebir M; Bouguern D; Sakho A; Demarchi P
    Saudi J Kidney Dis Transpl; 2017; 28(1):154-157. PubMed ID: 28098117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute effect of a peritoneal dialysis exchange on electrolyte concentration and QT interval in uraemic patients.
    Genovesi S; Nava E; Bartolucci C; Severi S; Vincenti A; Contaldo G; Bigatti G; Ciurlino D; Bertoli SV
    Clin Exp Nephrol; 2019 Nov; 23(11):1315-1322. PubMed ID: 31423549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium profiling in hemodiafiltration: a new way to reduce the calcium overload risk without compromising cardiovascular stability.
    Severi S; Bolasco P; Badiali F; Concas G; Mancini E; Summa A; Perazzini C; Steckiph D; Cagnoli L; Santoro A
    Int J Artif Organs; 2014 Mar; 37(3):206-14. PubMed ID: 24744165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety of intraperitoneal calcium therapy in a rodent model.
    Christenson M; Fivush B; Racusen L
    Adv Perit Dial; 1992; 8():15-7. PubMed ID: 1361773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peritoneal dialysis in the treatment of severe hypercalcemia.
    Hamilton JW; Lasrich M; Hirszel P
    J Dial; 1980; 4(2-3):129-38. PubMed ID: 7440844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.